Boehringer Ingelheim
Focus: Boehringer Ingelheim is a 53,000-person private pharmaceutical company headquartered in Germany with a diversified portfolio spanning respiratory, oncology, cardiovascular, immunology, and neuroscience. The company generates significant revenue from established blockbusters, particularly in chronic disease management.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
53,000
Open Jobs
0
About Boehringer Ingelheim
AI assessmentNot HiringNo open roles listed right now. Follow Boehringer Ingelheim to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthWatch
Pipeline
Early-stage
50 total
LOE Risk
2 imminent
SPIRIVA
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$8.8B Part DStable
Peak
Help build intelligence for Boehringer Ingelheim
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.